Faculty profile

Kathy Han

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Kathy Han

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
49 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Trial De-Escalation Therapy Decisional Conflict Endometrial Cancer Molecular Biomarker P53/Tp53 Personalized Cancer Treatment Pole

Latest papers

Multi-disciplinary management of advanced uterine sarcoma: a state of the art review.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2026
The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.
Clinical and translational radiation oncology · 2026
Should lymph node staging be tailored according to molecular profile in endometrial cancer?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2026

All 89 publications

Latest funding

Refining Adjuvant treatment IN endometrial cancer Based On molecular features (RAINBO) No Specific Molecular Profile (NSMP)-ORANGE trial
CIHR · 2026 · Co-investigator
$1,575,898
Lattice Radiation Therapy versus Conventional Radiation Therapy for the Palliation of Large Tumors (LATTICE-PAL)
CIHR · 2026 · Co-investigator
$960,076
Prediction and prevention of vaginal morbidity and female sexual dysfunction after pelvic radiotherapy
CIHR · 2024 · Co-investigator
$530,912

All 9 grants and awards

89 publications.

Multi-disciplinary management of advanced uterine sarcoma: a state of the art review.

Watson GA, Murtas F, Chawla T, Zhang L, Rouzbahman M, Pulenzas N, Toor H, Donnelly C, Han K, Croke J, Mackay H, Kim SR

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2026

DOI: 10.1016/j.ijgc.2026.104702 PMID: 42143439

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM

Clinical and translational radiation oncology2026

DOI: 10.1016/j.ctro.2026.101164 PMID: 42011409

Should lymph node staging be tailored according to molecular profile in endometrial cancer?

Dzyubak O, Moshkovich M, Watts M, Tarafdar O, Wei-Jia Lim J, Maganti M, Han K, Hodgson A, Ferguson SE, Kim SR

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2026

DOI: 10.1016/j.ijgc.2026.104712 PMID: 42134100

Contemporary issues in the multi-disciplinary management of early-stage uterine sarcoma.

Watson GA, Murtas F, Chawla T, Zhang L, Rouzbahman M, Pulenzas N, Toor H, Donnelly C, Han K, Croke J, Mackay H, Kim SR

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2026

DOI: 10.1016/j.ijgc.2026.104683 PMID: 42068680

Uterine Ultramover in Cervical Cancer Radiation Therapy: Retroversion and the Rationale for Online Adaptive Planning.

Riggenbach E, Tadic T, Han K

Practical radiation oncology2026Senior author

DOI: 10.1016/j.prro.2026.04.011 PMID: 42107765

Dosimetric Predictors of Sexual Toxicity in Cervical Cancer Patients Treated With Definitive Chemoradiation and Magnetic Resonance Imaging-Guided Brachytherapy.

Gulstene S, Chuk E, Conway J, Hanuschak J, Han K, Milosevic M, Lukovic J, Ferguson SE, Salman A, Santiago AT, Rink A, Croke JM

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2026.03.021 PMID: 41862031

Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.

Han K

Cancer2026First author

DOI: 10.1002/cncr.70352 PMID: 41823571

Retained Surgical Sponge in the Pelvis From Magnetic Resonance Imaging-Guided Cervix Brachytherapy.

Maina J, Benseler A, Dzyubak O, Bouchard-Fortier G, Ferguson SE, Skliarenko J, Han K

Practical radiation oncology2026Senior author

DOI: 10.1016/j.prro.2025.09.007 PMID: 41192762

Approaches to optimize the benefits of immunotherapy and immunotherapy combinations across endometrial cancer types.

Corr BR, Romano KD, Toboni MD, Fuh KC, Han K, Harkenrider MM, Kocherginsky M, Lindwasser OW, Mackay H, Martin LP, Campos SM, Kohn EC, Viswanathan AN, Duska LR

Journal of the National Cancer Institute2026

DOI: 10.1093/jnci/djag054 PMID: 41706908

Clinical Outcomes and Institutional Experience of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer.

Othman H, Barry A, Fyles A, Rodin D, Hahn E, Liu FF, Helou J, Han K, Glicksman R, Isfahanian N, Baskurt Z, Chan M, Purdie T, Koch A, Croke J

Advances in radiation oncology2026

DOI: 10.1016/j.adro.2025.101948 PMID: 41541755

Something wrong or missing on this profile? Suggest a correction

Kathy Han

Research

Latest papers

Latest funding

Multi-disciplinary management of advanced uterine sarcoma: a state of the art review.

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Should lymph node staging be tailored according to molecular profile in endometrial cancer?

Contemporary issues in the multi-disciplinary management of early-stage uterine sarcoma.

Uterine Ultramover in Cervical Cancer Radiation Therapy: Retroversion and the Rationale for Online Adaptive Planning.

Dosimetric Predictors of Sexual Toxicity in Cervical Cancer Patients Treated With Definitive Chemoradiation and Magnetic Resonance Imaging-Guided Brachytherapy.

Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.

Retained Surgical Sponge in the Pelvis From Magnetic Resonance Imaging-Guided Cervix Brachytherapy.

Approaches to optimize the benefits of immunotherapy and immunotherapy combinations across endometrial cancer types.

Clinical Outcomes and Institutional Experience of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer.

Frequent collaborators

Michael Milosevic

Jennifer Croke

Jelena Lukovic

Alexandra Rink

Stephanie Lheureux

Elizabeth Barnes

Fei-Fei Liu

David Jaffray

Danielle Rodin

Monica Serban

John Kim

Benjamin Haibe-Kains

Lisa Avery

Eitan Amir

Ivan Yeung

David Hedley

Elysia Donovan

Marianne Koritzinsky

Neesha Dhani

Warren Foltz

Xuan Li

Amy Liu

Cheryl Pritlove

Lisa Wang

Amy Jamieson

Michael Yan

Philippe Bedard

Allan Covens

Osvaldo Espin Garcia

Andrew Loblaw

Ranjan Sur

Eric Vigneault

Kara Schnarr

Lua Eiriksson

Raimond Wong

Thomas Purdie

Catherine Coolens